Key Points Rheumatoid arthritis (RA) therapy has changed dramatically over the past 20 years The early use of DMARDs, the use of DMARD combinations, and the use of biologic agents in patients who fail to respond to DMARDs are all part of the modern approach to treating RA Strategies involving the use of low-dose glucocorticoids, as well as more-aggressive glucocorticoid regimens, have been effective Despite these successes, there remains a considerable unmet need in RA therapy Many new therapies and strategies are currently being investigated, raising hopes for an even better future for patients with this disease This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Category 1 This category is made up of drugs which directly interact with receptors, including the classic nootropic piracetam (the inventor of which, Corneliu Giurgea, also coined the term nootropic) and the stimulants mentioned above
Cost: $139 per 30ml
From my initial consultation through three hour long treatments, I experienced high levels of professionalism and compassion
I get a voicemail, we want to write an article on your pharmacy
